Enterprise-scale platform Science Exchange operates a large-scale supplier orchestration platform for life sciences, with major clients like BMS, AbbVie, Gilead, and Astellas. Sales opportunities exist for expanding contract networks, increasing supplier onboarding, and offering premium procurement automation to similar large pharma companies.

AI driven enhancements Recent launches include Science Exchange Assistant and conversational analytics, signaling a push toward AI-enabled navigation and insights. Prospects include selling advanced AI-assisted workflow optimization, natural language query capabilities, and personalized analytics to accelerate R&D procurement decisions.

Expanded procurement Recent acquisitions and product expansions (HappiLabs, Clinical Development Solution, supplier punchout with BioIVT) indicate a strategy to broaden scientific procurement capabilities and supplier configuration. Focus sales on end-to-end sourcing, contract integration, and compliant invoicing across more life sciences segments.

Global supplier network With access to about 3,800 suppliers and integrated ELN data transfer, there is a clear upsell path for customers seeking broader supplier coverage, faster onboarding, and secure data exchange. Target mid-to-large life sciences teams looking to scale supplier ecosystems and digital marketplace reach.

Financial and scale signals Revenue in the 50–100 million range and a $78 million funding backdrop suggest a growing, investment-backed platform. Prioritize selling expansion into larger enterprise licenses, premium support, and tailor-made compliance modules to sustain rapid growth and enterprise onboarding.